The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant and adjuvant iruplinalkib in resectable ALK or ROS1 fusion-positive, non-small cell lung cancer (NSCLC): The preliminary results of the single-arm, exploratory Neo-INFINITY study.
 
Guodong Zhang
No Relationships to Disclose
 
Yong Liu
No Relationships to Disclose
 
Dijian Shen
No Relationships to Disclose
 
Yuejun Chen
No Relationships to Disclose
 
Yi He
No Relationships to Disclose
 
Hongyan Wang
No Relationships to Disclose
 
Lei Wang
No Relationships to Disclose
 
Hao Zhang
No Relationships to Disclose
 
Hua Zhang
No Relationships to Disclose
 
Jie Zhao
Employment - QiLu Pharmaceutical
 
Yaxiong Sang
Employment - QiLu Pharmaceutical
 
Meng Wang
Employment - QiLu Pharmaceutical
 
Hongxu Liu
No Relationships to Disclose
 
Jinshi Liu
No Relationships to Disclose
 
Xiaolong Yan
No Relationships to Disclose
 
Pingping Song
No Relationships to Disclose